Dr Reddy’s Laboratories (DRL) declined 1.07% to Rs 1200.95 after the US Food and Drug Administration (USFDA) concluded its Good manufacturing practice (GMP) inspection with seven observations at API manufacturing facility in Bollaram, Hyderabad.
| Subscribe To Our Free Newsletter |
